Clinical Profile of Skin Aging Based on Dermoscopy Photoaging Scale and Glogau Scale - Study of Leucocyte Telomere Length, Biomarker P16, and Body Mass Index
LTLP16
1 other identifier
observational
70
1 country
1
Brief Summary
To determine the relationship between clinical appearance, dermoscopic examination results of photoaging profiles based on clinical examination, DPAS score and leucocyte telomere length, to analyze the relationship between BMI, waist circumference, triglycerides, and cellular senescence biomarker p16 levels with a population experiencing skin aging and having Fitzpatrick III-V skin types. The questions which is aim to be answered are:
- 1.What is the photoaging profile based on clinical examination results in skin aging cases?
- 2.What is the photoaging profile based on DPAS scores in skin aging cases?
- 3.What is the leucocyte telomere length profile in skin aging cases?
- 4.What is the relationship between leucocyte telomere length and clinical examination in skin aging cases?
- 5.What is the relationship between leucocyte telomere length and DPAS degree in skin aging cases?
- 6.What is the profile of cellular senescence p16 biomarker levels in a population that has experienced clinical skin aging with Fitzpatrick III-V skin types?
- 7.What is the skin aging profile based on the Glogau and DPAS scales in a population with Fitzpatrick III-V skin types?
- 8.Is there a relationship between the results of the cellular senescence p16 biomarker examination and clinical skin aging assessed based on the Glogau and DPAS scales in a population with Fitzpatrick III-V skin types?
- 9.Is there a relationship between the results of BMI, waist circumference, and triglyceride examinations with clinical skin aging assessed using the Glogau and DPAS scales with Fitzpatrick III-V skin types?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2024
CompletedFirst Posted
Study publicly available on registry
January 16, 2025
CompletedStudy Start
First participant enrolled
February 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2025
CompletedJanuary 16, 2025
December 1, 2024
3 months
December 22, 2024
January 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
profile of leucocyte telomere length
profile of leucocyte telomere length in skin aging
1 year
profile of skin examination with dermoscopic photoaging scale (DPAS)
skin aging is assessed from dermoscopic photoaging scale on dermoscopic images, looking at pigmentary changes, vascular changes, telangiectasis, wrinkles, actinic keratoses, and blackheads. There are four facial regions assessed in the DPAS score calculation, namely the forehead, right cheek, left cheek, and chin. The sum of the scores of the four regions is assessed based on 11 parameters, with a maximum final score of 44. The greater the score, the higher marks of skin aging
1 year
Profile of body mass index
checking BMI to see if there is correlation so skin aging
1 year
profile of p16
checking p16 as a cellular senescence to skin aging
1 year
profile of waist circumference
Waist circumferemce will be checked, to see if there is correlation with skin aging
1 year
profile triglycerides
triglycerides will be checked, to see if there is correlation with skin aging
1 year
Study Arms (2)
leucocyte telomere length (LTL)
patients will be assessed LTL to see if there is correlation with body mass index, triglycerides, and skin aging
p16
patients will be assessed p16 to see if there is correlation with body mass index, triglycerides, and skin aging
Interventions
PCR method to see leucocyte telomere length
Eligibility Criteria
people with age from 31- 61 years
You may qualify if:
- female aged 31-61 years
- healthy
- willing to participate in the study
You may not qualify if:
- history of diseases (heart, kidney, liver)
- pregnant or breastfeeding patientes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitas Indonesia
Jakarta, DKI Jakarta, 10430, Indonesia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Irma Bernadette Sitohang, Prof IBSS Bernadette Sitohang, Proffesor
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. dr. Irma Bernadette S. Sitohang, Sp.DVE, Subsp. D.K.E
Study Record Dates
First Submitted
December 22, 2024
First Posted
January 16, 2025
Study Start
February 5, 2025
Primary Completion
May 20, 2025
Study Completion
August 20, 2025
Last Updated
January 16, 2025
Record last verified: 2024-12